Vascular benefits of rosigltazone and metformin compared with sulphonylurea and metformin combination therapy

Research output: Contribution to journal › Conference proceedings published in a journal › peer-review

Cite this

@article{35ed820b616b432797d4da5dd6ac1106,

title = "Vascular benefits of rosigltazone and metformin compared with sulphonylurea and metformin combination therapy",

author = "M Khanolkar and AW Thomas and SK Jackson and A Roberts and L George and J Geen and A Rees and RHK Morris and LM Evans",

year = "2005",

language = "English",

volume = "182",

pages = "S4--S4",

journal = "Atherosclerosis",

issn = "0021-9150",

publisher = "Elsevier Ireland Ltd",

number = "1",

}

TY - JOUR

T1 - Vascular benefits of rosigltazone and metformin compared with sulphonylurea and metformin combination therapy

AU - Khanolkar, M

AU - Thomas, AW

AU - Jackson, SK

AU - Roberts, A

AU - George, L

AU - Geen, J

AU - Rees, A

AU - Morris, RHK

AU - Evans, LM

PY - 2005

Y1 - 2005

M3 - Conference proceedings published in a journal

SN - 0021-9150

VL - 182

SP - S4-S4

JO - Atherosclerosis

JF - Atherosclerosis

IS - 1

ER -